LeMaitre Vascular Management
Management criteria checks 4/4
LeMaitre Vascular's CEO is George LeMaitre, appointed in Jun 1992, has a tenure of 31.92 years. total yearly compensation is $2.22M, comprised of 26.7% salary and 73.3% bonuses, including company stock and options. directly owns 9.75% of the company’s shares, worth $146.08M. The average tenure of the management team and the board of directors is 14.1 years and 18.5 years respectively.
Key information
George LeMaitre
Chief executive officer
US$2.2m
Total compensation
| CEO salary percentage | 26.7% |
| CEO tenure | 31.9yrs |
| CEO ownership | 9.7% |
| Management average tenure | 14.1yrs |
| Board average tenure | 18.5yrs |
Recent management updates
Recent updates
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Popularity With Investors Is Clear
May 02
Is Now The Time To Put LeMaitre Vascular (NASDAQ:LMAT) On Your Watchlist?
Apr 04Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Feb 29What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?
Jan 19Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Paint A Concerning Picture
Oct 27Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
Oct 11Does LeMaitre Vascular (NASDAQ:LMAT) Deserve A Spot On Your Watchlist?
Aug 30The Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Don't Inspire Confidence
Jul 06Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$62.3 Based On Its Intrinsic Value?
May 20Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?
Mar 12Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?
Oct 23Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Oct 05LeMaitre Vascular (NASDAQ:LMAT) Could Be Struggling To Allocate Capital
Sep 13LeMaitre Vascular: Reiterate Buy Thesis Following Strong Q2 Numbers
Sep 08LeMaitre Vascular goes ex dividend tomorrow
Aug 23LeMaitre Vascular: 16% Return Objective From Idiosyncratic Risk Premia
Jun 24What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?
Jun 15Are Investors Undervaluing LeMaitre Vascular, Inc. (NASDAQ:LMAT) By 40%?
May 06LeMaitre Vascular: Steady As She Goes
Apr 07With EPS Growth And More, LeMaitre Vascular (NASDAQ:LMAT) Is Interesting
Apr 02LeMaitre Vascular (NASDAQ:LMAT) Will Want To Turn Around Its Return Trends
Mar 15CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$593k | US$30m |
| Sep 30 2023 | n/a | n/a | US$27m |
| Jun 30 2023 | n/a | n/a | US$25m |
| Mar 31 2023 | n/a | n/a | US$21m |
| Dec 31 2022 | US$2m | US$568k | US$21m |
| Sep 30 2022 | n/a | n/a | US$21m |
| Jun 30 2022 | n/a | n/a | US$22m |
| Mar 31 2022 | n/a | n/a | US$27m |
| Dec 31 2021 | US$2m | US$473k | US$27m |
| Sep 30 2021 | n/a | n/a | US$28m |
| Jun 30 2021 | n/a | n/a | US$29m |
| Mar 31 2021 | n/a | n/a | US$24m |
| Dec 31 2020 | US$1m | US$311k | US$21m |
| Sep 30 2020 | n/a | n/a | US$19m |
| Jun 30 2020 | n/a | n/a | US$16m |
| Mar 31 2020 | n/a | n/a | US$18m |
| Dec 31 2019 | US$1m | US$438k | US$18m |
| Sep 30 2019 | n/a | n/a | US$19m |
| Jun 30 2019 | n/a | n/a | US$18m |
| Mar 31 2019 | n/a | n/a | US$23m |
| Dec 31 2018 | US$1m | US$438k | US$23m |
| Sep 30 2018 | n/a | n/a | US$21m |
| Jun 30 2018 | n/a | n/a | US$22m |
| Mar 31 2018 | n/a | n/a | US$18m |
| Dec 31 2017 | US$889k | US$162k | US$17m |
Compensation vs Market: George's total compensation ($USD2.22M) is below average for companies of similar size in the US market ($USD5.72M).
Compensation vs Earnings: George's compensation has been consistent with company performance over the past year.
CEO
George LeMaitre (58 yo)
31.9yrs
Tenure
US$2,220,797
Compensation
Mr. George W. LeMaitre has been Chief Executive Officer of Lemaitre Vascular, Inc. since June 1992 and has been its Chairman since 2004. Mr. LeMaitre served as the President of Lemaitre Vascular from June...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 31.9yrs | US$2.22m | 9.75% $ 146.1m | |
| President & Director | 16.8yrs | US$1.13m | 0.085% $ 1.3m | |
| CFO, Secretary & Director | 16.8yrs | US$1.07m | 0.039% $ 588.3k | |
| Senior Vice President of Operations | 19.3yrs | US$670.38k | 0.0071% $ 106.1k | |
| Founder and Chairman of Scientific Advisory Board | 41.3yrs | US$138.40k | no data | |
| VP & General Counsel | 1.1yrs | no data | no data | |
| Vice President of Marketing | 21.3yrs | no data | no data | |
| Senior Director of Human Resources | 4.3yrs | no data | no data | |
| Senior Vice President of Sales – Central Europe | less than a year | no data | no data | |
| Senior Vice President of Advanced Manufacturing Engineering | 1.3yrs | no data | no data | |
| Senior Vice President of Clinical | 11.3yrs | no data | no data | |
| Senior Vice President of EMEA Operations | 3.6yrs | no data | no data |
14.1yrs
Average Tenure
51yo
Average Age
Experienced Management: LMAT's management team is seasoned and experienced (14.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 31.9yrs | US$2.22m | 9.75% $ 146.1m | |
| President & Director | 23yrs | US$1.13m | 0.085% $ 1.3m | |
| CFO, Secretary & Director | 7.6yrs | US$1.07m | 0.039% $ 588.3k | |
| Founder and Chairman of Scientific Advisory Board | no data | US$138.40k | no data | |
| Independent Director | 21.3yrs | US$153.50k | 0.019% $ 281.2k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 15.7yrs | US$163.00k | 0.25% $ 3.8m | |
| Independent Director | 4.1yrs | US$144.50k | 0.0053% $ 78.7k |
18.5yrs
Average Tenure
59yo
Average Age
Experienced Board: LMAT's board of directors are seasoned and experienced ( 18.5 years average tenure).